55 results on '"Lim, Joseph K."'
Search Results
2. Chronic Hepatitis B Virus: What an Internist Needs to Know: Serologic Diagnosis, Treatment Options, and Hepatitis B Virus Reactivation
3. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review
4. The ALT upper reference interval debate: Blame it on the alcohol
5. AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review
6. Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation
7. Budd-Chiari Syndrome: An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed
8. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma
9. Hepatitis C: How Good Are Real-Life Data and Do Generics Work
10. Pathophysiology of Hepatic Encephalopathy
11. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review
12. Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study
13. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B
14. Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
15. Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis
16. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection
17. Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum
18. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
19. Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review
20. Non-responders to sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection
21. FRI-435 Serological and nucleic acid testing laboratory screening rates for hepatitis delta virus among adult patients in the United States
22. FRI-389 Hepatitis delta virus infection is associated with significantly greater incidence of cirrhosis and hepatic decompensation in U.S. veterans with chronic hepatitis B
23. Su1576 CANNABIS USE DISORDER IS ASSOCIATED WITH INCREASED RISK OF ACUTE MYOCARDIAL INFARCTION IN US ADULTS WITH MASH CIRRHOSIS: A POPULATION-BASED ANALYSIS
24. Sa1621 UNIVERSAL TESTING FOR HEPATITIS DELTA VIRUS (HDV) AMONG PATIENTS WITH CHRONIC HEPATITIS B DEMONSTRATES LOW PREVALENCE OF HDV INFECTION
25. Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
26. Introduction of Clinical Practice Update Committee Articles
27. Mo1545 EVALUATING HEPATITIS DELTA VIRUS DISEASE PREVALENCE AND PATIENT CHARACTERISTICS AMONG ADULTS IN THE UNITED STATES: AN ANALYSIS OF ALL-PAYER CLAIMS DATABASE
28. Sa1548 AN EXPLAINABLE ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HIGH-RISK NONALCOHOLIC STEATOHEPATITIS
29. 554 RISK OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA ACROSS A GRADIENT OF BASELINE HEPATITIS B VIRAL LOAD AMONG A NATIONAL COHORT OF PREDOMINANTLY NON-ASIAN VETERANS WITH CHRONIC HEPATITIS B IN THE UNITED STATES
30. Sa1523 ON-TREATMENT RISK OF HEPATOCELLULAR CARCINOMA DOES NOT DIFFER BY BASELINE HEPATITIS B VIRAL LOAD AMONG A LARGE COHORT OF PREDOMINANTLY NON-ASIAN PATIENTS WITH NON-CIRRHOTIC E ANTIGEN NEGATIVE CHRONIC HEPATITIS B
31. Reply
32. Endoscopic Approach to the Treatment of Gastrointestinal Bleeding
33. LEFT ATRIAL STRAIN AND DIASTOLIC DYSFUNCTION AMONGST HIV-POSITIVE INDIVIDUALS: INSIGHTS FROM THE VETERANS AGING COHORT STUDY
34. Squaric acid immunotherapy for warts in children
35. Simplifying the Diagnosis and Treatment of Hepatitis B Infection: One Step for Addressing Deficits in the Care Cascade, One Leap for Elimination
36. Tu1535 - Rising Healthcare Utilization and Cost of Chronic Hepatitis B: Real-World Analysis of 44,026 Chronic Hepatitis B Patients and 121,568 Matched Non-Chronic Hepatitis B Controls in the United States
37. Tu1533 - Prevalence of Osteoporosis and Bone Fracture was 2-Fold Higher in Chronic Hepatitis B Compared to Non-Chronic Hepatitis B Patients and Continued to Increase in the Last Decade: Results of a United States Population-Based Cohort Study
38. Mo1383 - Weight Change After Receipt of Direct-Acting Antiviral Agents for Hepatitis C
39. Sa1479 - 3 Times Higher Healthcare Cost in Chronic Hepatitis B Patients Compared to Non-Chronic Hepatitis B Controls Especially Those with Decompensated Liver Disease: United States Real World Healthcare Utilization and Cost Analysis
40. Sa1494 - Longitudinal Changes in Renal Function and Comorbidities in Treatment-Naïve and Treatment-Experienced Chronic Hepatitis B Patients in an US Insured Population: Analysis of a Real-World Cohort with Long-Term Follow-Up
41. Sa1492 - Higher Resource Utilization and Healthcare Costs in Treated Chronic Hepatitis B Patients with Chronic Kidney Disease
42. Sa1484 - Advancing Age and Comorbidities in Chronic Hepatitis B Patients: Results of 10-Year Longitudinal Analysis of a Diverse Population-Based Cohort of 44,026 Chronic Hepatitis B Patients in the United States
43. 347 - Hepatitis B Reactivation and Use of Pre-Emptive Hepatitis B Treatment in Cancer Patients Receiving Chemotherapy
44. 346 - Higher and Rising Prevalence and Incidence of Renal Impairment and Chronic Kidney Disease in Chronic Hepatitis B Patients Compared to Matched Non-Chronic Hepatitis B Controls in the United States: Results of a Real-World Analysis
45. Su1027 - Direct Healthcare Costs Associated with Osteoporosis and Bone Fracture in Pharmacologically Treated Chronic Hepatitis B Patients: Results of A United States Population-Based Cohort Study
46. Sa1463 - Receipt and Survival Outcomes of Curative Treatment for Hepatocellular Carcinoma by Etiology in the United States
47. 741a - Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy: Analysis of 11,243 Patients in a Major us Hospital Network 2012-2015
48. Use of endoclips in the treatment of massive colonic diverticular bleeding
49. Sa1091 Hepatitis C (HCV) Antiviral Therapy is Feasible in Patients With Active Substance use (SU) and Mental Illness (MI) and is More Likely to Occur in Those Who Receive Education Class
50. Sa1077 Telaprevir-Interferon-Ribavirin Trio Versus Interferon-Ribavirin Duo Therapy for Chronic Hepatitis C: A Sequential Analysis of Randomized Control Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.